Angel Biotechnology Holdings (LSE:ABH) Research & Development: £0.00 Mil (TTM As of Sep. 2012)


What is Angel Biotechnology Holdings Research & Development?

Angel Biotechnology Holdings LSE:ABH Research & Development is £0.00 Mil as of Sep. 2012. The stock has 2 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Angel Biotechnology Holdings's Research & Development for the six months ended in Sep. 2012 was £0.00 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Sep. 2012 was £0.00 Mil.

Angel Biotechnology Holdings  (LSE:ABH) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Angel Biotechnology Holdings Research & Development Related Terms

Angel Biotechnology Holdings Research & Development Historical Data

* Premium members only.

The historical data trend for Angel Biotechnology Holdings's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Angel Biotechnology Holdings Research & Development Chart

Angel Biotechnology Holdings Annual Data
Trend Dec02 Dec03 Dec04 Dec05 Dec07 Dec08 Dec09 Dec10 Mar12
Research & Development
Get a 7-Day Free Trial Premium Member Only 0.00 0.00 0.00 0.00 0.00

Angel Biotechnology Holdings Semi-Annual Data
Jun05 Dec05 Jun06 Jun07 Dec07 Jun08 Dec08 Jun09 Dec09 Jun10 Dec10 Jun11 Mar12 Sep12
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Angel Biotechnology Holdings Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Sep. 2012 adds up the semi-annually data reported by the company within the most recent 12 months, which was £0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of £0.00 Mil mean?
Angel Biotechnology Holdings (LSE:ABH) has a Research & Development of £0.00 Mil as of Sep. 2012. Research and development expense is the total cost for research and development activities. View historical data on Angel Biotechnology Holdings and its competitors.
Is Angel Biotechnology Holdings' Research & Development too high?
Angel Biotechnology Holdings' current Research & Development is £0.00 Mil.
How does Angel Biotechnology Holdings' Research & Development compare to competitors?
Angel Biotechnology Holdings' Research & Development of £0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Biotechnology company?
A good Research & Development depends on the Biotechnology industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Angel Biotechnology Holdings and its competitors. Angel Biotechnology Holdings's current Research & Development is £0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Angel Biotechnology Holdings stock overvalued right now?
Angel Biotechnology Holdings (LSE:ABH) has a current Research & Development of £0.00 Mil. The current Research & Development is £0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Angel Biotechnology Holdings (LSE:ABH), the current Research & Development is £0.00 Mil as of Sep. 2012. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.